CRI Logo
  • Media Room Article

    Three Cancer Research Institute Scientists to Receive 2011 Nobel Prize in Physiology or Medicine

    The Nobel Foundation announced yesterday that CRI-funded scientists Drs. Bruce Beulter, Jules Hoffmann, and Ralph Steinman will…

    octubre 4, 2011
  • Media Room Article

    Cancer Research Institute Announces Historic Change in Leadership

    CRI’s Board of Trustees has named James P. Allison, PhD, chair of the immunology program at Memorial…

    octubre 3, 2011
  • Media Room Article

    Cancer Vaccine Collaborative Clinical Trials Network Appoints New Director, Expands Leadership

    Jedd D. Wolchok, MD, PhD, a clinician scientist and director of immunotherapy clinical trials at Memorial Sloan-Kettering…

    septiembre 22, 2011
  • Media Room Article

    Cancer Research Institute to Honor Former Postdoctoral Fellow at 25th Annual Awards Dinner

    CRI announced today that Stephen C. Jameson, PhD, professor of laboratory medicine and pathology at the University…

    septiembre 8, 2011
  • Media Room Article

    Cancer Research Institute to Honor Pioneers in Adoptive Immunotherapy

    CRI announced today the winners of the 2011 William B. Coley Award for Distinguished Research in Tumor…

    septiembre 1, 2011
  • Media Room Article

    Cancer Research Institute Awards $9.7 Million in Grants to Support Tumor Immunology Research

    CRI announced today that it has awarded $9.7 million in grants to 26 scientists through its graduate…

    julio 6, 2011
  • Media Room Article

    FDA Approves New Immunotherapy for Metastatic Melanoma

    FDA announced today its approval of a new immunotherapy for advanced melanoma, the deadliest and most difficult-to-treat…

    marzo 25, 2011
  • Media Room Article

    New Perspectives on Cancer and the Immune System

    In a new article published in Science, three CRI scientists describe how advances in the field of…

    marzo 25, 2011
  • Media Room Article

    Cancer Research Institute Announces Second Investment from Its Cancer Vaccine Acceleration Fund to Enable Manufacture of Powerful Immune Stimulant

    CRI's Cancer Vaccine Acceleration Fund (CVAF) has completed a new investment agreement with biotech Oncovir to enable…

    enero 21, 2011

© 2025 Cancer Research Institute. All Trademarks referred to are the property of their respective owners.